# Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA CAR-NK Cell Injection for the Treatment of Refractory Pediatric Rheumatic Diseases

> **NCT07490041** · EARLY_PHASE1 · RECRUITING · sponsor: **The Children's Hospital of Zhejiang University School of Medicine** · enrollment: 36 (estimated)

## Conditions studied

- Rheumatic Diseases
- Pediatric Rheumatological Condition (i.e., Arthritis, SLE, Kawasaki's Disaese)
- Systemic Lupus Erythematosus (SLE)
- Connective Tissue Disease-associated Interstitial Lung Disease

## Interventions

- **BIOLOGICAL:** KN5601

## Key facts

- **NCT ID:** NCT07490041
- **Lead sponsor:** The Children's Hospital of Zhejiang University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-19
- **Primary completion:** 2026-12-19
- **Final completion:** 2027-12-19
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2026-03-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07490041

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07490041, "Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA CAR-NK Cell Injection for the Treatment of Refractory Pediatric Rheumatic Diseases". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07490041. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*